Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
66%
Brain Metastasis
50%
Melanoma
50%
Malignant Neoplasm
50%
Antimitotic Agent
50%
Multidrug Resistance
50%
Protein Tyrosine Kinase Inhibitor
50%
Blood-Brain Barrier
50%
Trastuzumab
50%
Estrogen Receptor
50%
Estrogen Receptor Positive Breast Cancer
50%
Taxane
42%
Effusion
35%
IC50
30%
Adenosine Triphosphatase
28%
ABCG2
21%
Tucatinib
16%
Trastuzumab Emtansine
16%
Neratinib
16%
Combination Drug
16%
Acid Phosphatase
16%
Western Blot
16%
Receptor
16%
Caspase 3
16%
Lapatinib
16%
Paclitaxel
14%
Lung Cancer
7%
Metastatic Melanoma
7%
Docetaxel
7%
Chemotherapy
7%
Biochemistry, Genetics and Molecular Biology
Annexin A2
100%
Estrogen Receptor
100%
Cancer Cell
91%
Fibronectin
66%
Gene Expression
57%
Blood Brain Barrier
50%
Posttranslational Modification
50%
Multidrug Resistance
50%
Trastuzumab
25%
Tyrosine Kinase Inhibitor
25%
IC50
22%
ABCG2
21%
ATPase
21%
Fibrous Protein
20%
Cell Function
20%
Programmed Cell Death
16%
Western Blot
13%
Mass Spectrometry
11%
Genetics
10%
Glycoprotein
10%
Trastuzumab Emtansine
8%
Lapatinib
8%
Neratinib
8%
Acid Phosphatase
8%
Antiproliferative Activity
8%
Signal Transduction
8%
Caspase 3
8%
Drug Sensitivity
7%
ATPase Assay
7%
RNA
7%
Cell Proliferation
7%
Epidermal Growth Factor
6%
Wound Healing
6%
Proteome
6%
Survival Rate
6%
Amino Acids
6%
Small Interfering RNA
6%
Immunoprecipitation
5%
Confocal Microscopy
5%
Medicine and Dentistry
Cancer Cell
50%
Extracellular Matrix
50%
Fibronectin
50%
Malignant Neoplasm
50%
Breast Cancer
50%
Gene Expression
50%
Neratinib
50%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
50%
Dasatinib
50%
In Vitro
50%
Breast Cancer Cell Line
29%
Cell Function
16%
Fibrous Protein
16%
Cell Line
14%
Targeted Therapy
12%
Trastuzumab
12%
Programmed Cell Death
12%
Protein Microarray
12%
Tumor Microenvironment
8%
Glycoprotein
8%
Cancer
8%
Signaling Molecule
8%
Clinical Assessment
8%
Breast Tumor
8%
Bioavailability
8%
Pathology of Breast Cancer
8%
Diseases
8%
Drug Effect
6%
Mitogen-Activated Protein Kinase
6%
Xenograft
6%
Leukemia
6%
Triple Negative Breast Cancer
6%
Antiproliferative Activity
6%
Estrogen Receptor
6%
Cell Migration
6%
Epidermal Growth Factor Receptor
6%
Neoplasm
6%
Phosphotransferase Inhibitor
6%
Protein Kinase B
6%
